Search Results - "Töllner, Kathrin"
-
1
Significant effects of sex, strain, and anesthesia in the intrahippocampal kainate mouse model of mesial temporal lobe epilepsy
Published in Epilepsy & behavior (01-02-2016)“…Abstract The intrahippocampal kainate mouse model of mesial temporal lobe epilepsy is increasingly being used for studies on epileptogenesis and…”
Get full text
Journal Article -
2
Effective termination of status epilepticus by rational polypharmacy in the lithium–pilocarpine model in rats: Window of opportunity to prevent epilepsy and prediction of epilepsy by biomarkers
Published in Neurobiology of disease (01-03-2015)“…Abstract The pilocarpine rat model, in which status epilepticus (SE) leads to epilepsy with spontaneous recurrent seizures (SRS), is widely used to study the…”
Get full text
Journal Article -
3
The organic anion transport inhibitor probenecid increases brain concentrations of the NKCC1 inhibitor bumetanide
Published in European journal of pharmacology (05-01-2015)“…Bumetanide is increasingly being used for experimental treatment of brain disorders, including neonatal seizures, epilepsy, and autism, because the neuronal…”
Get full text
Journal Article -
4
Isoflurane prevents acquired epilepsy in rat models of temporal lobe epilepsy
Published in Annals of neurology (01-12-2016)“…Objective Acquired epilepsy is a devastating long‐term risk of various brain insults, including trauma, stroke, infections, and status epilepticus (SE). There…”
Get full text
Journal Article -
5
The bumetanide prodrug BUM5, but not bumetanide, potentiates the antiseizure effect of phenobarbital in adult epileptic mice
Published in Epilepsia (Copenhagen) (01-05-2016)“…Summary Objective The loop diuretic bumetanide has been reported to potentiate the antiseizure activity of phenobarbital in rodent models of neonatal seizures,…”
Get full text
Journal Article -
6
Proof-of-concept that network pharmacology is effective to modify development of acquired temporal lobe epilepsy
Published in Neurobiology of disease (01-02-2020)“…Epilepsy is a complex network phenomenon that, as yet, cannot be prevented or cured. We recently proposed network-based approaches to prevent epileptogenesis…”
Get full text
Journal Article -
7
Evaluation of the pentylenetetrazole seizure threshold test in epileptic mice as surrogate model for drug testing against pharmacoresistant seizures
Published in Epilepsy & behavior (01-04-2016)“…Abstract Resistance to antiepileptic drugs (AEDs) is a major problem in epilepsy therapy, so that development of more effective AEDs is an unmet clinical need…”
Get full text
Journal Article -
8
Deletion of the Na-K-2Cl cotransporter NKCC1 results in a more severe epileptic phenotype in the intrahippocampal kainate mouse model of temporal lobe epilepsy
Published in Neurobiology of disease (01-05-2021)“…Increased neuronal expression of the Na-K-2Cl cotransporter NKCC1 has been implicated in the generation of seizures and epilepsy. However, conclusions from…”
Get full text
Journal Article -
9
Consequences of inhibition of bumetanide metabolism in rodents on brain penetration and effects of bumetanide in chronic models of epilepsy
Published in The European journal of neuroscience (01-02-2014)“…The diuretic bumetanide, which acts by blocking the Na–K–Cl cotransporter (NKCC), is widely used to inhibit neuronal NKCC1, particularly when NKCC1 expression…”
Get full text
Journal Article -
10
Brain endothelial TAK1 and NEMO safeguard the neurovascular unit
Published in The Journal of experimental medicine (21-09-2015)“…Inactivating mutations of the NF-κB essential modulator (NEMO), a key component of NF-κB signaling, cause the genetic disease incontinentia pigmenti (IP). This…”
Get full text
Journal Article -
11
Structure–activity relationships of bumetanide derivatives: correlation between diuretic activity in dogs and inhibition of the human NKCC2A transporter
Published in British journal of pharmacology (01-09-2015)“…Background and Purpose The N‐K‐Cl cotransporters (NKCCs) mediate the coupled, electroneutral movement of Na+, K+ and Cl− ions across cell membranes. There are…”
Get full text
Journal Article -
12
The novel antiepileptic drug imepitoin compares favourably to other GABA-mimetic drugs in a seizure threshold model in mice and dogs
Published in Pharmacological research (01-11-2013)“…Imepitoin potentiates GABAergic inhibition via the BZD site of the GABAA receptor but its affinity and intrinsic efficacy at this site are much lower compared…”
Get full text
Journal Article -
13
Gene therapy decreases seizures in a model of Incontinentia pigmenti
Published in Annals of neurology (01-07-2017)“…Objective Incontinentia pigmenti (IP) is a genetic disease leading to severe neurological symptoms, such as epileptic seizures, but no specific treatment is…”
Get full text
Journal Article -
14
Kindling as a model of temporal lobe epilepsy induces bilateral changes in spontaneous striatal activity
Published in Neurobiology of disease (01-03-2010)“…Abstract Basal ganglia are engaged in seizure propagation, control of seizures, and in epilepsy-induced neuroplasticity. Here, we tested the hypothesis that…”
Get full text
Journal Article -
15
Female Wistar rats obtained from different breeders vary in anxiety-like behavior and epileptogenesis
Published in Epilepsy research (01-03-2011)“…Summary Outbred rats are widely used in biomedical research studies. The genotypic variation, different housing and handling conditions during development, and…”
Get full text
Journal Article -
16
Cerebral influx of Na + and Cl - as the osmotherapy-mediated rebound response in rats
Published in Fluids and barriers of the CNS (25-09-2018)“…Cerebral edema can cause life-threatening increase in intracranial pressure. Besides surgical craniectomy performed in severe cases, osmotherapy may be…”
Get full text
Journal Article -
17
A novel prodrug-based strategy to increase effects of bumetanide in epilepsy
Published in Annals of neurology (01-04-2014)“…Objective There is considerable interest in using bumetanide, a chloride importer Na‐K‐Cl cotransporter antagonist, for treatment of neurological diseases,…”
Get full text
Journal Article -
18
Disruption of the sodium-dependent citrate transporter SLC13A5 in mice causes alterations in brain citrate levels and neuronal network excitability in the hippocampus
Published in Neurobiology of disease (01-09-2020)“…In addition to tissues such as liver, the plasma membrane sodium-dependent citrate transporter, NaCT (SLC13A5), is highly expressed in brain neurons, but its…”
Get full text
Journal Article -
19
Multiple blood-brain barrier transport mechanisms limit bumetanide accumulation, and therapeutic potential, in the mammalian brain
Published in Neuropharmacology (01-05-2017)“…There is accumulating evidence that bumetanide, which has been used over decades as a potent loop diuretic, also exerts effects on brain disorders, including…”
Get full text
Journal Article -
20
Network pharmacology for antiepileptogenesis: Tolerability and neuroprotective effects of novel multitargeted combination treatments in nonepileptic vs. post-status epilepticus mice
Published in Epilepsy research (01-03-2019)“…•Prevention of epilepsy in patients at risk is a major unmet clinical need.•Epilepsy is a network phenomenon, so its prevention may necessitate combinatorial…”
Get full text
Journal Article